Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Alessandro, Del Conte"'
Autor:
Elisa De Carlo, Elisa Bertoli, Monica Schiappacassi, Brigida Stanzione, Alessandro Del Conte, Roberto Doliana, Michele Spina, Alessandra Bearz
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Over the past decade, molecular characterization has led to change the management of advanced non-small cell lung cancer (NSCLC) harboring driver mutations. Rearranged during transfection (RET) gene fusions, occurring in 1% to 2% of NSCLC, have emerg
Externí odkaz:
https://doaj.org/article/bba8322347704220a1e389f3fbdd3567
Autor:
Mario Tamburrini, Dipti Gothi, Carlo Barbetta, Alessandro Del Conte, Sandro Sulfaro, Umberto Zuccon
Publikováno v:
Respiratory Medicine Case Reports, Vol 26, Iss , Pp 154-156 (2019)
A 45-year old man, chronic smoker with a pancoast tumor due to squamous cell carcinoma has been described. The initial diagnosis of lung carcinoma was based on a scant tissue so the exact cell typing was not possible. The initial treatment consisted
Externí odkaz:
https://doaj.org/article/d9d2e85e08c14670bee5b612bdedc692
Autor:
Stefano Indraccolo, PierFranco Conte, Alberto Amadori, Gian Luca De Salvo, Cinzia Candiotto, Roberta Bertorelle, Giorgia Nardo, Francesco Ciccarese, Massimo Moro, Gabriella Sozzi, Francesco Oniga, Marco Chilosi, Alessandro Del Conte, Antonio Santo, Adolfo Favaretto, Fiorella Calabrese, Giovanni Esposito, Elisabetta Zulato, Angela De Paoli, Laura Bonanno
Bonanno L. et al. Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1710cad7c1d2d48c792c38fe416302f8
https://doi.org/10.1158/1078-0432.22462281.v1
https://doi.org/10.1158/1078-0432.22462281.v1
Autor:
Stefano Indraccolo, PierFranco Conte, Alberto Amadori, Gian Luca De Salvo, Cinzia Candiotto, Roberta Bertorelle, Giorgia Nardo, Francesco Ciccarese, Massimo Moro, Gabriella Sozzi, Francesco Oniga, Marco Chilosi, Alessandro Del Conte, Antonio Santo, Adolfo Favaretto, Fiorella Calabrese, Giovanni Esposito, Elisabetta Zulato, Angela De Paoli, Laura Bonanno
Bonanno L. et al. Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5410c45ecb4a6f7fc2ebb82f8431ab06
https://doi.org/10.1158/1078-0432.22462278.v1
https://doi.org/10.1158/1078-0432.22462278.v1
Autor:
Stefano Indraccolo, PierFranco Conte, Alberto Amadori, Gian Luca De Salvo, Cinzia Candiotto, Roberta Bertorelle, Giorgia Nardo, Francesco Ciccarese, Massimo Moro, Gabriella Sozzi, Francesco Oniga, Marco Chilosi, Alessandro Del Conte, Antonio Santo, Adolfo Favaretto, Fiorella Calabrese, Giovanni Esposito, Elisabetta Zulato, Angela De Paoli, Laura Bonanno
Purpose: LKB1 is a key sensor of metabolic stress, including hypoxia and glucose deprivation, two features of the tumor microenvironment exacerbated by antiangiogenic therapy. We investigated the role of LKB1 as a potential predictive marker of sensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f9ae6849367c1516d46dbd1b4f9f50
https://doi.org/10.1158/1078-0432.c.6525066.v1
https://doi.org/10.1158/1078-0432.c.6525066.v1
Autor:
Francesco Cortiula, Giulia Pasello, Alessandro Follador, Giorgia Nardo, Valentina Polo, Elisa Scquizzato, Alessandro Del Conte, Marta Miorin, Petros Giovanis, Alessandra D’Urso, Salvator Girlando, Giulio Settanni, Vincenzo Picece, Antonello Veccia, Carla Corvaja, Stefano Indraccolo, Giovanna De Maglio
Publikováno v:
Diagnostics, Vol 10, Iss 10, p 765 (2020)
Background: circulating tumor DNA (ctDNA) is a source of tumor genetic material for EGFR testing in NSCLC. Real-word data about liquid biopsy (LB) clinical practice are lacking. The aim of the study was to describe the LB practice for EGFR detection
Externí odkaz:
https://doaj.org/article/ab89a24bd93a4d4bb3e5b3733b2c5dc5
Autor:
Andrea Camerini, Alessandro Del Conte, Aldo Pezzuto, Vieri Scotti, Francesco Facchinetti, Lucia Pia Ciccone, Marco Perna, Giulia Sartori, Cheti Puccetti, Alberto Ricci, Antonio Santo, Marcello Tiseo, Domenico Amoroso
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6074
Limited evidence is available concerning the selection criteria and the outcomes of platinum unfit newly diagnosed advanced NSCLC patients receiving single-agent chemotherapy. We retrospectively collected data on consecutive, stage IIIB-IV, EGFR/ALK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b698e548e0415c5463e200c7ed01d7c0
https://pubmed.ncbi.nlm.nih.gov/36551561
https://pubmed.ncbi.nlm.nih.gov/36551561
Publikováno v:
Expert Review of Precision Medicine and Drug Development. 6:299-305
Anaplastic lymphoma kinase (ALK) gene rearrangements and resulting fusion proteins occur in 3%-7% of patients with non-small-cell lung cancer (NSCLC), conferring sensitivity to treatment with ALK T...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ebe85e71ebf066413a169e62c06b396
https://doi.org/10.1080/23808993.2021.1954907
https://doi.org/10.1080/23808993.2021.1954907
Autor:
Elena Muraro, Carlo Furlan, Michele Avanzo, Debora Martorelli, Elisa Comaro, Aurora Rizzo, Damiana A. Fae’, Massimiliano Berretta, Loredana Militello, Alessandro Del Conte, Simon Spazzapan, Riccardo Dolcetti, Marco Trovo’
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Local irradiation of cancer through radiotherapy can induce spontaneous regression of non-directly irradiated lesions, suggesting the involvement of systemic antitumor immune responses. In oligometastatic breast cancer (BC) patients, the use of stere
Externí odkaz:
https://doaj.org/article/f00bf33f949342d2af6c4b7ab9ba19d6
Autor:
Emilio Minatel, Alessandra Bearz, Tanja Baresic, Umberto Zuccon, Carlo Furlan, Giovanni Franchin, Giuseppe Fanetti, Chiara Reverberi, A. Drigo, Marco Trovo, Jerry Polesel, Loredana Barresi, Alessandro Del Conte, Fabio Matrone, Elena Muraro, Paolo Fontana, Alberto Relevant
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 109:1368-1376
Purpose We conducted a phase 3 randomized clinical trial to assess whether radical hemithoracic radiation therapy (RHR) compared with palliative radiation therapy (PR) can achieve overall survival (OS) advantages in patients with malignant pleural me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bbcacad1011b70837e567ae826265c5
https://doi.org/10.1016/j.ijrobp.2020.11.057
https://doi.org/10.1016/j.ijrobp.2020.11.057